Vuong Trieu - 29 Jan 2025 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Issuer symbol: OTLC
Transactions as of: 29 Jan 2025
Net transactions value: +$9,712
Form type: 4
Filing time: 31 Jan 2025, 17:08:22 UTC
Previous filing: 26 Nov 2024
Next filing: 10 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$5,126	+183,066	+0.2%	$0.0280	93,025,782	29 Jan 2025	Direct
transaction	OTLC	Common Stock	Purchase	$2,800	+100,003	+0.11%	$0.0280	93,125,785	30 Jan 2025	Direct
transaction	OTLC	Common Stock	Purchase	$1,786	+63,775	+0.07%	$0.0280	93,189,560	31 Jan 2025	Direct
holding	OTLC	Common Stock						16,780,384	29 Jan 2025	By Autotelic, Inc.
holding	OTLC	Common Stock						6,872,529	29 Jan 2025	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Between January 29, 2025 and January 31, 2025, Dr. Trieu purchased 346,844 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.028.